Interferon-γ Inhibits 1,25-Dihydroxyvitamin D3- Stimulated Synthesis of Bone GLA Protein in Rat Osteosarcoma Cells by a Pretranslational Mechanism*
- 1 August 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 127 (2) , 588-594
- https://doi.org/10.1210/endo-127-2-588
Abstract
Interferon-.gamma. (IFN) is produced by lymphocytes in areas of inflammation and connective tissue destruction. IFN inhibits collagen and DNA synthesis in cultured rat long bones and osteoblastic ROS 17/2.8 cells, suggesting that the periarticular loss of bone that occurs in inflammatory joint diseases may be due to IFN inhibition of bone formation. Since serum levels of bone gla protein (BGP) have been correlated with the bone formation rate, we studied the effect of IFN on production of this osteoblast-specific protein and steady state BGP messenger RNA (mRNA) levels in ROS 17/2.8 cells. RIA of BGP was done using an antibody raised against rat BGP43-50 peptide. BGP synthesis was stimulated with 10-8 M 1,25-dihydroxyvitamin D3 24 h before continuously after addition of recombinant rat IFN. IFN (100 U/ml) inhibited BGP secretions 52%, 78%, and 70% in the first, second, and third 24 h periods after IFN treatment, compared to control cells cultured with 1,25-dihydroxyvitamin D3 alone. The ED50 for IFN inhibition of BGP production was 3.3 U/ml (0.29 nM). Pulse labeling with [14C] leucine or [3H]proline during the last 4 h of culture revealed that IFN (3-100 U/ml) did not inhibit total protein secretion into the medium. The percent inhibition of BGP production by IFN was independent of media serum concentration or cell density. IFN (100 U/ml) decreased the steady state level of BGP mRNA as measured by Northern analysis using an oligomeric probe for rat BGP. The decrease in hybridization signal for BGP mRNA was detectable by 1 h after IFN exposure and continued to decline at 6 and 24 h. Treatment with cycloheximide (5 .mu.g/ml) blocked the inhibitory effect of IFN on steady state levels of BGP mRNA. These results suggest that IFN may inhibit bone formation by selective inhibition of osteoblast matrix protein production. The mechanism of IFN inhibition of BGP production is at least in part, pretranslational.This publication has 29 references indexed in Scilit:
- Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation.The Journal of Experimental Medicine, 1985
- Cloning and expression of the chromosomal immune interferon gene of the rat.The EMBO Journal, 1985
- SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1984
- Inhibition of parathormone-stimulated bone resorption by Type I interferonBiochemical and Biophysical Research Communications, 1984
- Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production.The Journal of cell biology, 1982
- 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells.Journal of Biological Chemistry, 1980
- Parathyroid Hormone-Responsive Clonal Cell Lines from Rat Osteosarcoma*Endocrinology, 1980
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- The osteoporosis of rheumatoid arthritisArthritis & Rheumatism, 1965